In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: Enhanced expression in psoriatic skin

Journal of Immunology

Volumn 176, Issue 3, 2006, Pages 1908-1915

  Piskin, Gamze ^a   Sylva Steenland, Regien M R ^a   Bos, Jan D ^a   Teunissen, Marcel B M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23; MESSENGER RNA; PROTEIN P19; PROTEIN P40;

ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MEMORY T LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; STATISTICAL ANALYSIS; SUPERNATANT; WESTERN BLOTTING;

EID: 31144441631     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.3.1908     Document Type: Article

References (40)

1. Bos, J. D., and M. L. Kapsenberg. 1993. The skin immune system: progress in cutaneous biology. Immunol. Today 14: 75-78.
2. Grone, A. 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88: 1-12.
3. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α. Arch. Dermatol. Res. 289: 277-284.
4. Robinson, D. S., and A. O'Garra. 2002. Further checkpoints in Th1 development. Immunity 16: 755-758.
5. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. c. Familletti, et al. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88: 4143-4147.
6. Strengell, M., S. Matikainen, J. Sirén, A. Lehtonen, D. Foster, I. Julkunen, and T. Sareneva. 2003. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170: 5464-5469.
7. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
8. Enk, C. D., S. Mahanty, A. Blauvelt, and S. I. Katz. 1996. UVB induces IL-12 transcription in human keratinocytes in vivo and in vitro. Photochem. Photobiol. 63: 854-859.
9. Hong, K., A. Chu, B. R. Ludviksson, E. L. Berg, and R. O. Ehrhardt. 1999. IL-12, independently of IFN-γ, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J. Immunol 162: 7480-7491.
10. Hamid, Q., T. Naseer, E. M. Minshall, Y. L. Song, M. Boguniewicz, and D. Y. Leung. 1996. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98: 225-231.
11. Austin, L. M., M. Ozawa, T. Kikuchi, I. B. Walters, and J. G. Krueger. 1999. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 113: 752-759.
12. Yawalkar, N., S. Karlen, R. Hunger, C. U. Brand, and L. R. Braathen. 1998. Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 111: 1053-1057.
13. + perivascular dendritic cells. J. Invest. Dermatol. 96: 333-340.
14. Bos, J. D., and M. A. de Rie. 1999. The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today 20: 40-46.
15. Piskin, G., C. W. Koomen, D. Picavet, J. D. Bos, and M. B. M. Teunissen. 2003. Ultraviolet-B irradiation decreases IFN-γ and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. Exp. Dermatol. 12: 172-180.
16. Vissers, J. L., F. C. Hartgers, E. Lindhout, M. B. M. Teunissen, C. G. Figdor, and G. J. Adema. 2001. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukocyte Biol. 69: 785-793.
17. Piskin, G., U. Tursen, R. M. Sylva-Steenland, J. D. Bos, and M. B. M. Teunissen. 2004. Clinical improvement in chronic plaque-type psoriasis lesions after narrowband UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers: IL-12, IL-18 and IL-23. Exp. Dermatol. 13: 764-772.
18. Piskin, G., R. M. Sylva-Steenland, J. D. Bos, and M. B. M. Teunissen. 2004. T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-γ expression. Arch. Dermatol. Res. 295: 509-516.
19. Müller, G., J. Saloga, T. Germann, I. Bellinghausen, M. Mohamadzadeh, J. Knop, and A. H. Enk. 1994. Identification and induction of human keratinocyte-derived IL-12. J. Clin. Invest. 94: 1799-1805.
20. Yawalkar, N., A. Limat, C. U. Brand, and L. R. Braathen. 1996. Constitutive expression of both subunits of interleukin-12 in human keratinocytes. J. Invest. Dermatol. 106: 80-83.
21. Becker, C., S. Wirtz, M. Blessing, J. Pirhonen, D. Strand, O. Bechthold, J. Frick, P. R. Galle, I. Autenrieth, and M. F. Neurath. 2003. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112: 693-706.
22. McLellan, A. D., R. V. Sorg, L. A. Williams, and D. N. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur. J. Immunol. 26: 1204-1210.
23. Gaspari, A. A., G. D. Sempowski, P. Chess, J. Gish, and R. P. Phipps. 1996. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur. J. Immunol. 26: 1371-1377.
24. Ozawa, H., S. Nakagawa, H. Tagami, and S. Aiba. 1996. Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J. Invest. Dermatol. 106: 441-445.
25. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669-674.
26. Denfeld, R. W., D. Hollenbaugh, A. Fehrenbach, J. M. Weiss, A. von Leoprechting, B. Mai, U. Voith, E. Schopf, A. Aruffo, and J. C. Simon. 1996. CD40 is functionally expressed on human keratinocytes. Eur. J. Immunol. 26: 2329-2334.
27. Gueniche, A., J. Viac, M. Charveron, and D. Schmitt. 1994. Effect of γ-interferon on IL-1α, β and receptor antagonist production by normal human keratinocytes. Exp. Dermatol 3: 113-118.
28. Boyman, O., H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle. 2004. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199: 731-736.
29. Ghilardi, N., N. Kljavin, Q. Chen, S. Lucas, A. L. Gurney, and F. J. de Sauvage. 2004. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172: 2827-2833.
30. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
31. Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, and J. K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436.
32. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
33. Wiekowski, M. T., M. W. Leach, E. W. Evans, L. Sullivan, S. C. Chen, G. Vassileva, J. F. Bazan, D. M. Gorman, R. A. Kastelein, S. Narula, and S. A. Lira. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166: 7563-7570.
34. Kopp, T., J. D. Kieffer, A. Rot, S. Strommer, G. Stingl, and T. S. Kupper. 2001. Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40. J. Invest. Dermatol. 117: 618-626.
35. Kopp, T., P. Lenz, C. Bello-Fernandez, R. A. Kastelein, T. S. Kupper, and G. Stingl. 2003. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J. Immunol. 170: 5438-5444.
36. Bata-Csorgo, Z., C. Hammerberg, J. J. Voorhees, and K. D. Cooper. 1995. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture: cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J. Clin. Invest. 95: 317-327.
37. Teunissen, M. B. M., C. W. Koomen, M. de Waal, E. A. Wierenga, and J. D. Bos. 1998. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111: 645-649.
38. Belladonna, M. L., J. C. Renauld, R. Bianchi, C. Vacca, F. Fallarino, C. Orabona, M. C. Fioretti, U. Grohmann, and P. Puccetti. 2002. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 168: 5448-5454.
39. Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Kraeger. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with Psoriasis vulgaris. J. Exp. Med. 199: 125-130.
40. Kauffman, C. L., N. Aria, E. Toichi, T. S. McCormick, K. D. Cooper, A. B. Gottlieb, D. E. Everitt, B. Frederick, Y. Zhu, M. A. Graham, et al. 2004. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J. Invest. Dermatol. 123: 1037-1044.